Targeting epithelial-mesenchymal transition and cancer stem cells for chemoresistant ovarian cancer

Chemoresistance is the main challenge for the recurrent ovarian cancer therapy and responsible for treatment failure and unfavorable clinical outcome. Understanding mechanisms of chemoresistance in ovarian cancer would help to predict disease progression, develop new therapies and personalize system...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Junli, Wang, Li, Chen, Hongmin, Hao, Jingli, Ni, Jie, Chang, Lei, Duan, Wei, Graham, Peter, Li, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342453/
https://www.ncbi.nlm.nih.gov/pubmed/27304054
http://dx.doi.org/10.18632/oncotarget.9908

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342453/
https://www.ncbi.nlm.nih.gov/pubmed/27304054
http://dx.doi.org/10.18632/oncotarget.9908

Ejemplares similares